HREC

Tokyo, Japan, August 25, 2026 Astellas Pharma Inc. announced that the first patient has been dosed in a Phase...

Shanghai and Hong Kong, China, August 25, 2026 Antengene Corporation Limited announced that the Phase I ATTRACT clinical study...

SINGAPORE and NORTH BRUNSWICK, N.J., Aug. 3, 2026 Adlai Nortye Ltd. has advanced its oncology pipeline after submitting a...